Mesoblast (MESO) Receivables - Other (2017 - 2019)

Mesoblast's (MESO) quarterly Receivables - Other came in at $1.5 million in Q2 2019, up 143.9% year-on-year from $615000.0 in Q2 2018, and up 519.83% quarter-over-quarter from $242000.0 in Q3 2018.

Mesoblast (MESO) Receivables - Other (2017 - 2019) Analysis & Trends

Mesoblast has disclosed Receivables - Other across 3 years of filings, most recently posting $1.5 million for Q2 2019.

  • Receivables - Other for Q2 2019 came in at $1.5 million, up 143.9% year-over-year; the trailing twelve-month figure through Jun 2019 was $1.5 million (up 143.9% YoY), and the FY2019 annual result was $1.5 million, up 143.9% from the prior year.
  • Receivables - Other came in at $1.5 million for Q2 2019 at Mesoblast, up from $242000.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $1.5 million in Q2 2019 to a low of $196000.0 in Q3 2017.
  • The 3-year median for Receivables - Other is $698000.0 (2017), against an average of $818000.0.
  • Across the five-year window, Receivables - Other dropped 11.89% in 2018 and jumped 143.9% in 2019, its largest moves.
  • Mesoblast's Receivables - Other stood at $1.5 million in 2017, then plunged by 83.49% to $242000.0 in 2018, then soared by 519.83% to $1.5 million in 2019.
  • The last three Receivables - Other figures came in at $1.5 million (Q2 2019), $242000.0 (Q3 2018), and $615000.0 (Q2 2018), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Mesoblast 21.68 Bn 21.55 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2019 1.50 Mn
Jun 30, 2019 1.50 Mn
Sep 30, 2018 242,000.00
Sep 30, 2018 242,000.00
Jun 30, 2018 615,000.00
Jun 30, 2018 615,000.00
Mar 31, 2018 1.01 Mn
Mar 31, 2018 1.01 Mn
Dec 31, 2017 1.47 Mn
Dec 31, 2017 1.47 Mn
Sep 30, 2017 196,000.00
Sep 30, 2017 196,000.00
Jun 30, 2017 698,000.00
Jun 30, 2017 698,000.00